These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24702881)

  • 21. [NSAID urticaria: Similar management to acute urticaria].
    Khandzian M; Hacard F; Braire-Bourrel M; Jaulent C; Bérard F; Nicolas JF; Nosbaum A
    Rev Med Interne; 2019 Mar; 40(3):166-172. PubMed ID: 30630637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NSAID single-drug-induced reactions.
    Woessner KM; Castells M
    Immunol Allergy Clin North Am; 2013 May; 33(2):237-49. PubMed ID: 23639711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of nonsteroidal inflammatory drug-induced urticaria and/or angioedema.
    Nosbaum A; Braire-Bourrel M; Dubost R; Faudel A; Parat S; Nicolas JF; Bérard F
    Ann Allergy Asthma Immunol; 2013 Apr; 110(4):263-6. PubMed ID: 23535090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diclofenac-induced urticaria with aspirin tolerance.
    Gala G; Blanco R; Quirce S; Pérez-Camo I; Alvarez-Fernández JA; Díez-Gómez ML
    Allergy; 1998 Jun; 53(6):623-4. PubMed ID: 9689349
    [No Abstract]   [Full Text] [Related]  

  • 25. Pseudo-allergic reactions--PAR.
    Kallós P; Schlumberger HD
    Int Arch Allergy Appl Immunol; 1987; 82(1):1-3. PubMed ID: 2948919
    [No Abstract]   [Full Text] [Related]  

  • 26. Challenge-based clinical patterns of 223 Spanish patients with nonsteroidal anti-inflammatory-drug-induced-reactions.
    Quiralte J; Blanco C; Delgado J; Ortega N; Alcntára M; Castillo R; Anguita JL; Sáenz de San Pedro B; Carrillo T
    J Investig Allergol Clin Immunol; 2007; 17(3):182-8. PubMed ID: 17583106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed-type hypersensitivity rash from ibuprofen.
    Nettis E; Giordano D; Colanardi MC; Paradiso MT; Ferrannini A; Tursi A
    Allergy; 2003 Jun; 58(6):539-40. PubMed ID: 12757466
    [No Abstract]   [Full Text] [Related]  

  • 28. Natural evolution in patients with nonsteroidal anti-inflammatory drug-induced urticaria/angioedema.
    Doña I; Barrionuevo E; Salas M; Cornejo-García JA; Perkins JR; Bogas G; Prieto A; Torres MJ
    Allergy; 2017 Sep; 72(9):1346-1355. PubMed ID: 28226401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema.
    Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
    Ann Allergy Asthma Immunol; 2005 Aug; 95(2):154-8. PubMed ID: 16136765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NSAID-induced urticaria/angioedema does not evolve into chronic urticaria: a 12-year follow-up study.
    Doña I; Blanca-López N; Torres MJ; Gómez F; Fernández J; Zambonino MA; Monteseirín FJ; Canto G; Blanca M; Cornejo-García JA
    Allergy; 2014 Apr; 69(4):438-44. PubMed ID: 24372026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib.
    Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):34-8. PubMed ID: 15702813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NSAID-induced urticaria and angioedema: a reappraisal of its clinical management.
    Sánchez-Borges M; Capriles-Hulett A; Caballero-Fonseca F
    Am J Clin Dermatol; 2002; 3(9):599-607. PubMed ID: 12444802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Angio-oedema and urticaria as side effects of frequently used drugs].
    Hoefnagel JJ; Wehmeijer K; Terreehorst I; van Zuuren EJ
    Ned Tijdschr Geneeskd; 2010; 154():A1854. PubMed ID: 20719007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-reactivity and tolerability of celecoxib in adult patients with NSAID hypersensitivity.
    Li L; Laidlaw T
    J Allergy Clin Immunol Pract; 2019; 7(8):2891-2893.e4. PubMed ID: 31100553
    [No Abstract]   [Full Text] [Related]  

  • 35. Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response.
    Doña I; Blanca-López N; Cornejo-García JA; Torres MJ; Laguna JJ; Fernández J; Rosado A; Rondón C; Campo P; Agúndez JA; Blanca M; Canto G
    Clin Exp Allergy; 2011 Jan; 41(1):86-95. PubMed ID: 21155908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs.
    Torres MJ; Barrionuevo E; Kowalski M; Blanca M
    Immunol Allergy Clin North Am; 2014 Aug; 34(3):507-24, vii-viii. PubMed ID: 25017675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term tolerability of etoricoxib in patients with previous reactions to non-steroidal anti-inflammatory drugs.
    Di Leo E; Aloia AM; Nettis E; Cardinale F; Foti C; Distaso M; Ferrannini A; Vacca A
    Int J Immunopathol Pharmacol; 2009; 22(4):1131-4. PubMed ID: 20074479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safe full-dose one-step nabumetone challenge in patients with nonsteroidal anti-inflammatory drug hypersensitivity.
    Confino-Cohen R; Goldberg A
    Allergy Asthma Proc; 2003; 24(4):281-4. PubMed ID: 12974196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced phenotyping in hypersensitivity drug reactions to NSAIDs.
    Ayuso P; Blanca-López N; Doña I; Torres MJ; Guéant-Rodríguez RM; Canto G; Sanak M; Mayorga C; Guéant JL; Blanca M; Cornejo-García JA
    Clin Exp Allergy; 2013 Oct; 43(10):1097-109. PubMed ID: 24074328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs)].
    Boehncke S; Boehncke WH
    Dtsch Med Wochenschr; 2005 Oct; 130(40):2249-52. PubMed ID: 16208597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.